Effects of hydrogen inhalation on nasal microflora in patients with allergic rhinitis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200062253

Enrollment

Unknown

Registered

2022-07-31

Start date

2022-07-31

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Goup H:Inhalation of hydrogen gas

Group C:Inhalation of oxygen

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. For patients with allergic rhinitis, clinical anaphylaxis is required to have symptoms and have been confirmed to have symptomatic allergic rhinitis by skin or in vitro tests. 2. The patient had not received immunotherapy or other drugs within 4 weeks. 3. Aged >=18 years and able to give informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors; 2. Poor compliance; 3. Patients with sinusitis and nasal polyps.

Design outcomes

Primary

Measure	Time frame
The bacterial flora distribution;	—

Countries

China

Contacts

Public ContactWang Jingting

Harbin Medical University

5433@hrbmu.edu.cn+86 13674664313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026